drug · Product Intelligence

Tocilizumab
Pipeline Intelligence

Tocilizumab: 3 indexed trials, 3 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.

⚗
3Indexed trials
▦
3Sponsors
⌁
0Orange Book patent links
◎
0FDA-linked events

Development evidence

NCT03062579Fu-Dong Shi · multiple_sclerosisPHASE1, PHASE2
NCT04888221Assistance Publique - Hôpitaux de Paris · strokePHASE3
NCT07263776Capital Medical University · strokePHASE3

FDA / patent evidence

No FDA Orange Book product match is asserted for this intervention.

Regulatory context

FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.